News Focus
News Focus
icon url

BeDub

12/21/12 3:13 PM

#31242 RE: takeachance2012 #31241

Who wouldn't want to get excited about a similar pharma deal for Fuse? There's a wide gap however between the current state of their technology and the ones described in that article. It could happen -- and the Mayan calendar may signal the end of the world at the end of the day. I guess we'll find out.



icon url

shore18

12/21/12 3:34 PM

#31244 RE: takeachance2012 #31241

TAC, my main thought is that this reaffirms something that we have discussed here numerous times. Big pharma is not shy about investing in new technologies. The article you posted states Halozyme stands to make 500 million plus royalties from the deal. The company, which I don't believe makes money, has their stock trading at 7.00 per share. It is valued at about 700 million dollars.!! As it could one day relate to Fuse, well, as they say, do the math!